Regions
Regentis Biomaterials Announces $10 Million Raised in Latest Round of Funding
Investment to expand clinical use of innovative cartilage regeneration implant GelrinC™ Regentis Biomaterials Ltd. , a privately held company focused on developing proprietary hydrogels for tissue regeneration, has raised $10 million in its latest round of funding from new investors Royal DSM through its venturing subsidiary and from Crossroad Fund, as well as from existing investors Medica Venture Partners, SCPVitalife and the Technion Investment Opportunities Fund.
Cedar Realty Trust Announces Pricing Of Public Offering Of Its 7.25% Series B Cumulative Redeemable Preferred Stock
Cedar Realty Trust, Inc. (NYSE: CDR) has priced an underwritten public offering of 400,000 shares of its 7.25% Series B Cumulative Redeemable Preferred Stock at $23.00 per share.
Ridgeline Announces Bought Deal of $10 Million Following Upsizing from $2 Million
Ridgeline Energy Services Inc. (TSX-V: RLE; OTCQX: RGDEF) announced its bought deal offering on May 14, 2012 of 2,857,000 common shares in the capital of Ridgeline at $0.70 per Common Share.
Venture Atlanta Provides the Backbone for Entrepreneur Growth and Funding in Georgia
Conference for and by entrepreneurs now seeking dynamic presenting companies Venture Atlanta, Georgia’s premiere event connecting technology innovation and investment capital, today issued a call for presenters at its annual investor event to be held October 17-18, 2012 at the Georgia Aquarium.